Raymond James Financial Inc Novo Cure LTD Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Raymond James Financial Inc holds 11,662 shares of NVCR stock, worth $223,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,662
Previous 11,672
0.09%
Holding current value
$223,677
Previous $347,000
40.35%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$233 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$216 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$172 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$106 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$100 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.01B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...